Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graeme Moyle

Showing results (11-20 of 120) with videos related to

Pageof 12
Sort By:
International Journal of STD & AIDS|October 22, 2005
A review of the aetiology of dyslipidaemia and hyperlipidaemia in patients with HIVGraeme Moyle
Journal of Acquired Immune Deficiency Syndromes (1999)|May 26, 2007
Metabolic issues associated with protease inhibitorsGraeme Moyle
Journal of HIV Therapy|July 9, 2004
Mitochondrial toxicity: myths and factsGraeme Moyle
The AIDS Reader|February 7, 2003
Double "d" drug dangerGraeme Moyle
HIV Clinical Trials|February 11, 2003
Selected topics from the Sixth International Congress on Drug Therapy in HIV infection; November 17-21, 2002; Glasgow, United KingdomGraeme Moyle
Lancet (London, England)|February 14, 2004
Managing HIV lipoatrophyGraeme Moyle, Jussi Sutinen
HIV Clinical Trials|March 16, 2002
HIV-associated lipodystrophy, metabolic complications, and antiretroviral toxicitiesGraeme Moyle, Andrew Carr
AIDS Reviews|March 12, 2004
The clades of HIV: their origins and clinical significanceJustin Stebbing, Graeme Moyle
AIDS (London, England)|April 13, 2004
Antiretroviral nucleoside and nucleotide analogues and mitochondriaAndrea Cossarizza, Graeme Moyle
Clinical Medicine (London, England)|July 16, 2008
HIV and cardiovascular riskGraeme Moyle, Paul Randell
Pageof 12

Showing results (11-20 of 120) with videos related to

Sort By:
Pageof 12
International Journal of STD & AIDS|October 22, 2005
A review of the aetiology of dyslipidaemia and hyperlipidaemia in patients with HIVGraeme Moyle
Journal of Acquired Immune Deficiency Syndromes (1999)|May 26, 2007
Metabolic issues associated with protease inhibitorsGraeme Moyle
Journal of HIV Therapy|July 9, 2004
Mitochondrial toxicity: myths and factsGraeme Moyle
The AIDS Reader|February 7, 2003
Double "d" drug dangerGraeme Moyle
HIV Clinical Trials|February 11, 2003
Selected topics from the Sixth International Congress on Drug Therapy in HIV infection; November 17-21, 2002; Glasgow, United KingdomGraeme Moyle
Lancet (London, England)|February 14, 2004
Managing HIV lipoatrophyGraeme Moyle, Jussi Sutinen
HIV Clinical Trials|March 16, 2002
HIV-associated lipodystrophy, metabolic complications, and antiretroviral toxicitiesGraeme Moyle, Andrew Carr
AIDS Reviews|March 12, 2004
The clades of HIV: their origins and clinical significanceJustin Stebbing, Graeme Moyle
AIDS (London, England)|April 13, 2004
Antiretroviral nucleoside and nucleotide analogues and mitochondriaAndrea Cossarizza, Graeme Moyle
Clinical Medicine (London, England)|July 16, 2008
HIV and cardiovascular riskGraeme Moyle, Paul Randell
Pageof 12